Page 2 - Scientific Library
New SARS-CoV/ACE2 inhibitor assays & small molecules for drug discovery
Many initiatives led by worldwide scientific networks are currently being launched to decipher cellular mechanisms involved in SARS-CoV-2 cellular entry. For example, a recent study has
What is the connection between COVID-19 severity and gene expression in immune cells?
The immune system, responsible for fighting off infections and diseases, refers to multiple biological processes that have different functions and contributions to the immune system and its response to
What diseases are linked to Microbiota disturbance?
The microbiota is the set of microbial organisms in a community, generally used in reference to an animal host. The digestive microbiota is the most common.
What we call a microbiome is the set
New cancer treatment may reawaken the immune system
Cancer is a disease caused by abnormal cell growth. The cells’ genetic material is corrupted and the metabolic processes do not interact well with them anymore. They grow unchecked, mostly in the form
How can CRISPR/Cas9 be used to edit genomes?
Genes are key components of our lives. With many other factors, they contribute to shaping us, making people and any other living organism what they are. Genomes, whether human or not, are able
Accelerate Your Oncology Research With Advanced Solutions
Your source for comprehensive tools, services, and insights for the latest cancer research
Master ADME-Tox Research with Expert Products & Services
Gain insights, explore essential tools, and discover reliable services to drive your ADME-Tox research success.
Empowering Immunology Research with Precision Products and Services
Production of eGFP mRNA Labeled with Fluorophore for Tracking of Delivery and Expression
Our Contract Research Services (CRS) team developed eGFP mRNA labeled with a fluorophore to monitor its delivery and expression efficiency in cells.
RNA Production Platform and the Associated Solutions Facilitate the Development of RNA-Based Vaccines
RNA vaccines have shown their full potential in the Covid-19 pandemic. The application of these technologies for the treatment of cancers represents a significant promise, but clinical effectiveness remains